---
id: CVE-2017-17678
title: BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS)
summary: >-
  BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A
  DOM-based cross-site scripting vulnerability was discovered in a legacy
  utility.
severity: medium
cvss: 6.1
cvssVector: 'CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N'
cwe:
  - CWE-79
vendor: bmc
product: remedy_mid-tier
affected:
  - remedy_mid-tier = 9.1
published: '2021-05-19'
updated: '2026-07-05'
source: NVD
sourceUrl: 'https://nvd.nist.gov/vuln/detail/CVE-2017-17678'
references:
  - url: >-
      https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html
    label: cve@mitre.org
  - url: 'https://seclists.org/fulldisclosure/2017/Oct/52'
    label: cve@mitre.org
  - url: 'http://bmc.com'
    label: af854a3a-2127-422b-91ae-364da2661108
  - url: 'http://remedy.com'
    label: af854a3a-2127-422b-91ae-364da2661108
  - url: >-
      https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html
    label: af854a3a-2127-422b-91ae-364da2661108
  - url: 'https://seclists.org/fulldisclosure/2017/Oct/52'
    label: af854a3a-2127-422b-91ae-364da2661108
tags:
  - nvd
epss: 0.00591
epssPercentile: 0.46709
ingestedAt: '2026-07-06T01:08:16.741Z'
---

## Overview

BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.

## Affected

- `remedy_mid-tier = 9.1`

## Remediation

Refer to the linked advisories for vendor-supplied fixes and affected version ranges.